trifluoperazine has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rizzuti, B | 1 |
| Lan, W | 1 |
| Santofimia-Castaño, P | 1 |
| Zhou, Z | 1 |
| Velázquez-Campoy, A | 1 |
| Abián, O | 1 |
| Peng, L | 1 |
| Neira, JL | 1 |
| Xia, Y | 1 |
| Iovanna, JL | 1 |
1 other study available for trifluoperazine and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Design of Inhibitors of the Intrinsically Disordered Protein NUPR1: Balance between Drug Affinity and Target Function.
Topics: Adenocarcinoma; Animals; Basic Helix-Loop-Helix Transcription Factors; Calorimetry; Carcinoma, Pancr | 2021 |